News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Forest Laboratories, Inc. (FRX), Almirall's COPD Drug Tied to Increased Deaths, FDA Says


2/21/2012 8:44:50 AM

Forest Laboratories Inc. (FRX) and Almirall SA (ALM)’s experimental drug to treat breathing complications tied to a common lung disease may be linked to higher instances of cardiovascular deaths, U.S. regulators said today. The twice-daily drug known chemically as aclidinium bromide helped patients with chronic obstructive pulmonary disease, or COPD, breathe easier, Food and Drug Administration staff said today in a report. Advisers to the agency are set to meet Feb. 23 to weigh whether safety questions concerning the medicine have been adequately assessed.

Read at Bloomberg
Read at Chicago Tribune


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES